Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Why Oxygen Stigma Persists, With Mike Hess, MPH Mike Hess, MPH

Published Date: 22 Oct 2026

On World Oxygen Day, the COPD Foundation's Mike Hess outlines the stigma, training gaps, and Medicare barriers affecting patients on supplemental oxygen.

When to Switch Biologics in Severe Asthma, With Florence Schleich, MD, PhD Florence Schleich, MD, PhD

Published Date: 22 Oct 2026

Schleich says biologic switching in severe asthma should follow exacerbation phenotyping and discusses response predictors and standardized follow-up.

Lower Baseline FVC Linked to Better Sarcoidosis Treatment Response Vivienne Kahlmann

Published Date: 22 Oct 2026

A post-hoc PREDMETH analysis presented at ERS 2026 links lower baseline FVC and shorter disease duration with greater FVC gains on first-line therapy.

Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT

Published Date: 22 Oct 2026

Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT

Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD

Published Date: 22 Oct 2026

Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD

Real-World Data Back Stiripentol’s Effect on Seizures in Dravet Syndrome Marco Meglio

Published Date: 22 Oct 2026

A retrospective 10-center U.S. study found stiripentol reduced convulsive seizure frequency, status epilepticus episodes, and emergency health care use in patients with Dravet syndrome.

Diazepam Nasal Spray Terminates Most Pediatric Status Epilepticus Episodes in Seizure Clusters, Post Hoc Analysis Shows Isabella Ciccone, MPH

Published Date: 22 Oct 2026

Newly presented post hoc analyses examined diazepam nasal spray for status epilepticus in seizure clusters and intervals between clusters in children, alongside real-world data on rescue medication prescribing.

Amyloid Vaccine AV-1959R Generates Antibodies in All Phase 1 Recipients Louie Pasculli

Published Date: 22 Oct 2026

In a 16-person placebo-controlled trial, every cognitively unimpaired adult given AV-1959R developed anti-amyloid-beta antibodies, while placebo recipients stayed at baseline.

Clene Submits NDA Seeking Accelerated Approval for ALS Drug Marco Meglio

Published Date: 22 Oct 2026

Clene has filed an NDA seeking accelerated approval of CNM-Au8 for ALS, following 2 missed primary trial endpoints and years of evolving FDA guidance.

Decade of OPERA Data Supports Early Ocrelizumab Treatment Initiation in Relapsing Multiple Sclerosis Isabella Ciccone, MPH

Published Date: 22 Oct 2026

A newly published 10-year analysis of the OPERA I and II trials reported that starting ocrelizumab 2 years earlier was associated with less disability accrual in relapsing MS, with no new safety signals.

Knowledge Hub

Oncology

Pediatric Tumor Microenvironment Models for Laboratory Research

A comprehensive review of laboratory models for the pediatric tumor microenvironment, highlighting clinical significance and emerging research.

Oncology

Macrocycle Therapeutics for Cancer Targets: Advances, Mechanisms, and Clinical Implications

Review of macrocycle therapeutics as emerging cancer treatments, mechanisms, advances, and clinical implications.

Oncology

Physical Recovery During Cancer Survivorship: Mechanisms, Evidence, and Clinical Strategies

A comprehensive review of physical recovery strategies, mechanisms, and guideline-based management during cancer survivorship.

Oncology

Immune Niches Supporting Tumor Dormancy

Comprehensive review of immune niches in tumor dormancy, mechanisms, and clinical implications for relapse prevention.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Why Oxygen Stigma Persists, With Mike Hess, MPH Mike Hess, MPH

When to Switch Biologics in Severe Asthma, With Florence Schleich, MD, PhD Florence Schleich, MD, PhD

Lower Baseline FVC Linked to Better Sarcoidosis Treatment Response Vivienne Kahlmann

Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT

Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD

Real-World Data Back Stiripentol’s Effect on Seizures in Dravet Syndrome Marco Meglio

Diazepam Nasal Spray Terminates Most Pediatric Status Epilepticus Episodes in Seizure Clusters, Post Hoc Analysis Shows Isabella Ciccone, MPH

Amyloid Vaccine AV-1959R Generates Antibodies in All Phase 1 Recipients Louie Pasculli

Clene Submits NDA Seeking Accelerated Approval for ALS Drug Marco Meglio

Decade of OPERA Data Supports Early Ocrelizumab Treatment Initiation in Relapsing Multiple Sclerosis Isabella Ciccone, MPH

Knowledge Hub

Pediatric Tumor Microenvironment Models for Laboratory Research

Macrocycle Therapeutics for Cancer Targets: Advances, Mechanisms, and Clinical Implications

Physical Recovery During Cancer Survivorship: Mechanisms, Evidence, and Clinical Strategies

Immune Niches Supporting Tumor Dormancy

Immune-Engaging Antibody Platforms: Mechanisms, Clinical Applications, and Emerging Therapeutics

Smart Oncology Infusion Chairs With Integrated Treatment Data: Transforming Chemotherapy Delivery and Patient Monitoring

Intracellular Nanobody Therapeutics: Mechanisms, Clinical Relevance, and Emerging Applications

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Why Oxygen Stigma Persists, With Mike Hess, MPH Mike Hess, MPH

When to Switch Biologics in Severe Asthma, With Florence Schleich, MD, PhD Florence Schleich, MD, PhD

Lower Baseline FVC Linked to Better Sarcoidosis Treatment Response Vivienne Kahlmann

Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT

Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD

Real-World Data Back Stiripentol’s Effect on Seizures in Dravet Syndrome Marco Meglio

Diazepam Nasal Spray Terminates Most Pediatric Status Epilepticus Episodes in Seizure Clusters, Post Hoc Analysis Shows Isabella Ciccone, MPH

Amyloid Vaccine AV-1959R Generates Antibodies in All Phase 1 Recipients Louie Pasculli

Clene Submits NDA Seeking Accelerated Approval for ALS Drug Marco Meglio

Decade of OPERA Data Supports Early Ocrelizumab Treatment Initiation in Relapsing Multiple Sclerosis Isabella Ciccone, MPH

Knowledge Hub

Pediatric Tumor Microenvironment Models for Laboratory Research

Macrocycle Therapeutics for Cancer Targets: Advances, Mechanisms, and Clinical Implications

Physical Recovery During Cancer Survivorship: Mechanisms, Evidence, and Clinical Strategies

Immune Niches Supporting Tumor Dormancy

Immune-Engaging Antibody Platforms: Mechanisms, Clinical Applications, and Emerging Therapeutics

Smart Oncology Infusion Chairs With Integrated Treatment Data: Transforming Chemotherapy Delivery and Patient Monitoring

Intracellular Nanobody Therapeutics: Mechanisms, Clinical Relevance, and Emerging Applications

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views